Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

These days, one doesn’t experience the news on these platforms before seeing the memes and reactions—the reaction and the ...

Former Google CEO Eric Schmidt declared his own programming expertise obsolete after watching an AI system autonomously ...

The strategic insertion of the past is no longer incidental in Bollywood films. It has become a deliberate trope in ...

As previously mentioned, all ten of the sefirot are found within each individual sefirah (recursively), demonstrating total ...

Between Choice and Fate at Batsford Gallery has a very charged yet subtle quality. The gallery’s atmosphere seems more akin ...

Fruchter, G. (2026) Opportunism in Supply Chain Recommendations: A Dynamic Optimization Approach. Modern Economy, 17, 26-38.

Introduction Application of artificial intelligence (AI) tools in the healthcare setting gains importance especially in the domain of disease diagnosis. Numerous studies have tried to explore AI in ...

This article, presented in the backdrop of the debates on the state of political theory in India, argues that the terms of ...